Gene Therapy for Metachromatic Leukodystrophy (TIGET-MLD)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Fondazione Telethon
GlaxoSmithKline
Information provided by (Responsible Party):
Alessandra Biffi, IRCCS San Raffaele
ClinicalTrials.gov Identifier:
NCT01560182
First received: March 16, 2012
Last updated: April 20, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2023
  Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)